1 Graves DT, Barnhill R, Calanopoulos T, et al. Expressionof monocyte chemotactic protein-1 in human melanoma in vivo. Am J Pathol, 1992,140:9-14. 2 Carr MW, Roth SJ, Luther E, et al. Monocyte chemoattractant protein 1acts as aT-lymphocyte chemoattractant. Proc Natl Acad Sci USA, 1994,91:3652-3656. 3 Zheng M, Yang H, Mrowietz U. Isolation of human monocyte subpopulation by single-step counterflow centrifugation elutriation by a Sanderson chamber. Clin Biot echnol, 1991,3:197-203. 4 Zheng M, Sun GJ, Mrowietz U. The chemotactic activity of T-lymphocytes inresponse to interleukin 8 is significantly decreased in patients with psoriasis and atopic dermatitis. Exp Dermatol, 1996,5:334-340. 5 Mrowietz U, Jurgens G. A method for the determination of leukocyte migrationfor large sample numbers by automated densitometric quantification. J Biochem Biophys Methods, 1995,30:49-58. 6 Mantovani A, Bottazzi B, Colotta F, et al. The origin and function of tumor-associated macrophages. Immunol Today, 1992,13:265-270. 7 Elder DE, Van Belle P, Elenitsas R, et al. Neoplastic progression and prognosis in melanoma. Semin Cutan Med Surg, 1996,15:336-348. 8 Mueller R, Zheng M, Mrowietz U. Significant reduction of human monocytechemotatic response to monocyte-chemotactic protein 1 in patients with primary and metastatic malignant melanoma. Exp Dermatol, 1997,6:81-86. 9 Oin S, LaRosa G, Campbell JJ, et al. Expression of monocyte chemoattractant protein-1 and interleukin-8 receptor on subsets of T cells:correlation with transendothelial chemotactic potential. Eur J Immunol, 1996,26:640-647. |